Bristol-Myers Squibb Co
BMY63
$57.33arrow_drop_up1.72%$0.97
S&P500
BMY63
$57.33
arrow_drop_up1.72%Performance History
| Key Stats | |
|---|---|
| Open | $56.22 |
| Prev. Close | $56.30 |
| EPS | -3.58 |
| Next Earnings Date | May 8, 2025 |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 55.72 | 57.46 |
| 52 Week Range | 39.35 | 62.22 |
| Ratios | |
|---|---|
| EPS | -3.58 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Bristol-Myers Squibb Co (BMY)
- Sector
- Healthcare
- Industry
- Drug Manufacturers—General
- CEO
- Dr. Giovanni Caforio M.D.
- Headquarters
- New York
- Employees
- 34300
- Exchange
- NYSE
Keep an eye on Bristol-Myers Squibb Co
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Bristol-Myers Squibb Co's (BMY) price per share?
The current price per share for Bristol-Myers Squibb Co (BMY) is $57.33. The stock has seen a price change of $0.97 recently, indicating a 1.72% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Bristol-Myers Squibb Co (BMY)?
For Bristol-Myers Squibb Co (BMY), the 52-week high is $62.22, which is 8.53% from the current price. The 52-week low is $39.35, the current price is 45.69% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Bristol-Myers Squibb Co (BMY) a growth stock?
Bristol-Myers Squibb Co (BMY) has shown an average price growth of -4.38% over the past three years. It has received a score of 46 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Bristol-Myers Squibb Co as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Bristol-Myers Squibb Co (BMY) stock price performance year to date (YTD)?
As of the latest data, Bristol-Myers Squibb Co (BMY) has a year-to-date price change of 8.66%. Over the past month, the stock has experienced a price change of -0.95%. Over the last three months, the change has been 16.03%. Over the past six months, the figure is 39.69%. Looking at a longer horizon, the five-year price change stands at -9.73%.
help
Is Bristol-Myers Squibb Co (BMY) a profitable company?
Bristol-Myers Squibb Co (BMY) has a net income of $8.04B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 76.24% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 18.48% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $45.01B, although specific revenue growth data is currently not available. The gross profit is $34.31B. Operating income is noted at $17.24B. Furthermore, the EBITDA is $18.41B.
help
What is the market capitalization of Bristol-Myers Squibb Co (BMY)?
Bristol-Myers Squibb Co (BMY) has a market capitalization of $116.28B. The average daily trading volume is 57.05, indicating the stock's liquidity and investor engagement.